GENE ONLINE|News &
Opinion
Blog

Taiwan
Micronbrane Medical Aspires to Further Clinical Collaboration Following the Successful Series A Funding
2022-12-01Partner
CK Life Sciences and CK Hutchison Invest in Taiwanese Liquid Biopsy Candidate
2022-07-26
Reinvigorating the Asian Biomedical Ecosystem With BIO Asia-Taiwan 2022
2022-07-26Partner
Taiwan Greenlights BMS, Ono’s Opdivo For Frontline Esophageal Cancer
2022-07-20
New Kind of Cell Division Without DNA Replication
2022-05-12
APCM 2022: Precision Medicine Is Opening Up a New Prospect of Cancer Therapy
2022-05-04Partner
AMS BioteQ Touts Antimicrobial Dressings for Chronic Wound Infections
2022-04-13Partner
Bavarian Nordic Establishes Asia Link for Its RSV Vaccines
2022-03-24
HCmed and Formosa Laboratories Join Forces to Create CDMO for Inhaled Drugs
2022-03-08
UK and Taiwan to Cooperate for Breakthrough in Digital Health Innovations
2022-02-25
Moderna Announces Plan to Set Up Subsidiaries in APAC to Provide mRNA Technology Service
2022-02-16
How Our Microbiomes Are Connected to Irritable Bowel Syndromes, Cancer and Autism: Highlights from the 6th Asia Microbiome Conference
2022-02-14
Digital Health Programme to Connect British and Taiwanese Leaders
2022-01-17Partner
After Winning Approval for Its Painkiller in Thailand, Taiwan’s Lumosa Aims for Korea Nod
2022-01-02
How CDMOs are Restructuring the Biopharma Landscape – An Interview with Bobby Sheng
2021-12-06
1 2 3 4
LATEST
OncoC4 Bags $200 Million In CTLA-4 Antibody Pact With BioNTech
2023-03-21
HHS Issues Initial Guidance on Negotiation Program as Government’s Latest Move to Reduce Drug Prices
2023-03-21
First-Ever Insect Brain Neuron Map Completed
2023-03-21
AbbVie Unveils Latest Data For Skyrizi In Difficult-To-Treat Psoriasis
2023-03-20
Sanofi Slashes Insulin Prices by Up to 78% Following Hot On the Heels of Major Competitors
2023-03-19
Novartis Snags Pediatric Brain Cancer Indication for Oncology Combination Therapy
2023-03-19
Pfizer, Astellas’ Prostate Cancer Drug Xtandi Achieves Goals In Phase 3
2023-03-19
Scroll to Top